PubMed COVID-19 Clinical Care

CONCLUSION: Our findings suggest an association between the use of sevoflurane and improved outcomes in C-ARDS patients requiring invasive mechanical ventilation. However, due to the single-center, retrospective design of the study, caution should be

CONCLUSIONS: In an acute phase of COVID-19, the elevation of cardiac biomarkers in patients with normal left ventricular ejection fraction is a frequent occurrence; however, it does not translate into clinically significant cardiac dysfunction after

Introduction Intestinal parasitic infections continue to loom in developing countries with low sanitation and socioeconomic conditions. Pandemic times are especially important to study the prevalence of these pathogens since the focus of all

CONCLUSIONS: There was a significant decline in the number of BE and BE-related dysplasia diagnoses during the COVID-19 pandemic, with an almost 50% reduction in the amount of dysplasia diagnosed in the early pandemic. The absence of a compensatory

This study proposes the Structured Multi-criteria Model of Self-Managed Motivation in Organizations based on happiness at work. Employees need to be motivated in order to be efficient at doing a particular task at the workplace. As young people born

CONCLUSIONS: COVID-19 death rates and PMRs varied by sex, industry, and occupation groups. These findings underscore the importance of workplace public health interventions, which could protect workers and their communities.

CONCLUSION: COVID-19 vaccines in RA patients was not associated with an increase in AESI risk or health care utilization after every dose.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to a global pandemic of coronavirus disease 2019 (COVID-19). Early in the pandemic, efforts were made to test the SARS-CoV-2 antiviral efficacy of repurposed medications that were

No abstract

BACKGROUND: Booster COVID-19 vaccines have shown efficacy in clinical trials and effectiveness in real-world data against symptomatic and severe illness. However, some people still become infected with SARS-CoV-2 following a third (booster)